4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-038076
CEO and Chairman sold 69,680 shares at an average $44.57 ($3,105,912)
- CEO and Chairman acquired 69,680 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBINS CHAD M CEO and Chairman | 2020-06-17 | Option exercise | +28,440 | $0.33 | $9,385 | 1,806,620 | D |
| ROBINS CHAD M CEO and Chairman | 2020-06-17 | Sale | −400 | $43.76 | $17,504 | 1,806,220 | D |
| ROBINS CHAD M CEO and Chairman | 2020-06-17 | Sale | −28,040 | $44.38 | $1,244,415 | 1,778,180 | D |
| ROBINS CHAD M CEO and Chairman | 2020-06-18 | Option exercise | +16,680 | $0.33 | $5,504 | 1,794,860 | D |
| ROBINS CHAD M CEO and Chairman | 2020-06-18 | Sale | −16,680 | $44.41 | $740,759 | 1,778,180 | D |
| ROBINS CHAD M CEO and Chairman | 2020-06-19 | Option exercise | +24,560 | $0.33 | $8,105 | 1,802,740 | D |
| ROBINS CHAD M CEO and Chairman | 2020-06-19 | Sale | −24,160 | $44.91 | $1,085,026 | 1,778,580 | D |
| ROBINS CHAD M CEO and Chairman | 2020-06-19 | Sale | −400 | $45.52 | $18,208 | 1,778,180 | D |
| Derivatives | |||||||
| ROBINS CHAD M CEO and Chairman | 2020-06-17 | Option exercise · Stock Option (Right to Buy) | −28,440 | 423,120 | D | ||
| ROBINS CHAD M CEO and Chairman | 2020-06-18 | Option exercise · Stock Option (Right to Buy) | −16,680 | 406,440 | D | ||
| ROBINS CHAD M CEO and Chairman | 2020-06-19 | Option exercise · Stock Option (Right to Buy) | −24,560 | 381,880 | D | ||
| Open-market sales · 69,680 sh · avg $44.57 · $3,105,912 | |||||||
Loading xslF345X03/doc4.xml…